Lista de obras -

A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumours

artículo científico publicado en 2013

An Outpatient, Dose-Intense, Intravenous Cisplatin and Oral Etoposide Regimen for the Treatment of Advanced, Platinum-Resistant Ovarian Cancer

artículo científico publicado en 2018

Characterisation and risk assessment of venous thromboembolism in gastrointestinal cancers

artículo científico publicado en 2017

Circulating Tumor Cell Enumeration in a Phase II Trial of a Four-Drug Regimen in Advanced Colorectal Cancer

artículo científico publicado en 2014

Dose-dense cisplatin with gemcitabine for relapsed platinum-resistant ovarian cancer

scientific article published on 23 January 2019

Evaluation of hypertension and proteinuria as markers of efficacy in antiangiogenic therapy for metastatic colorectal cancer

artículo científico publicado en 2014

Heparin octasaccharides inhibit angiogenesis in vivo.

artículo científico publicado en 2005

Intra-tumoural microvessel density in human solid tumours.

artículo científico publicado en 2002

Mainstreaming germline BRCA1/2 testing in non-mucinous epithelial ovarian cancer in the North West of England

scientific article published on 10 July 2020

Malignant bowel obstruction in advanced ovarian cancer.

artículo científico publicado en 2017

Novel Anti-angiogenic Therapies in Ovarian Cancer

Outcomes after multiple lines of chemotherapy for platinum-resistant epithelial cancers of the ovary, peritoneum, and fallopian tube

artículo científico publicado en 2011

Pazopanib and Fosbretabulin in recurrent ovarian cancer (PAZOFOS): A multi-centre, phase 1b and open-label, randomised phase 2 trial

artículo científico publicado en 2020

Plasma Tie2 is a tumor vascular response biomarker for VEGF inhibitors in metastatic colorectal cancer

artículo científico publicado en 2018

Prevalence of germline pathogenic BRCA1/2 variants in sequential epithelial ovarian cancer cases

scientific article published on 25 January 2019

Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC): Updated analysis of 93 randomised patients - control survival is much better than previously assumed

artículo científico publicado en 2020

Quantifying antivascular effects of monoclonal antibodies to vascular endothelial growth factor: insights from imaging

artículo científico publicado en 2009

Quantitative angiogenesis assays in vivo--a review.

artículo científico publicado en 2004

Randomised Controlled Trial Evidence Questions the Assumption that Pulmonary Metastasectomy Benefits Patients with Colorectal Cancer

artículo científico publicado en 2021

Role of front-line bevacizumab in advanced ovarian cancer: the OSCAR study

artículo científico publicado en 2019

Screening tool for malignant bowel obstruction in relapsed, metastatic ovarian cancer

artículo científico publicado en 2019

Targeted therapies in epithelial ovarian cancer

The Impact of Changes in Service Delivery in Patients With Colorectal Cancer During the Initial Phase of the COVID-19 Pandemic

artículo científico publicado en 2020

Lista de obras de

A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumours

An Outpatient, Dose-Intense, Intravenous Cisplatin and Oral Etoposide Regimen for the Treatment of Advanced, Platinum-Resistant Ovarian Cancer

Characterisation and risk assessment of venous thromboembolism in gastrointestinal cancers

Circulating Tumor Cell Enumeration in a Phase II Trial of a Four-Drug Regimen in Advanced Colorectal Cancer

Dose-dense cisplatin with gemcitabine for relapsed platinum-resistant ovarian cancer

Evaluation of hypertension and proteinuria as markers of efficacy in antiangiogenic therapy for metastatic colorectal cancer

Heparin octasaccharides inhibit angiogenesis in vivo.

Intra-tumoural microvessel density in human solid tumours.

Mainstreaming germline BRCA1/2 testing in non-mucinous epithelial ovarian cancer in the North West of England

Malignant bowel obstruction in advanced ovarian cancer.

Novel Anti-angiogenic Therapies in Ovarian Cancer

Outcomes after multiple lines of chemotherapy for platinum-resistant epithelial cancers of the ovary, peritoneum, and fallopian tube

Pazopanib and Fosbretabulin in recurrent ovarian cancer (PAZOFOS): A multi-centre, phase 1b and open-label, randomised phase 2 trial

Plasma Tie2 is a tumor vascular response biomarker for VEGF inhibitors in metastatic colorectal cancer

Prevalence of germline pathogenic BRCA1/2 variants in sequential epithelial ovarian cancer cases

Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC): Updated analysis of 93 randomised patients - control survival is much better than previously assumed

Quantifying antivascular effects of monoclonal antibodies to vascular endothelial growth factor: insights from imaging

Quantitative angiogenesis assays in vivo--a review.

Randomised Controlled Trial Evidence Questions the Assumption that Pulmonary Metastasectomy Benefits Patients with Colorectal Cancer

Role of front-line bevacizumab in advanced ovarian cancer: the OSCAR study

Screening tool for malignant bowel obstruction in relapsed, metastatic ovarian cancer

Targeted therapies in epithelial ovarian cancer

The Impact of Changes in Service Delivery in Patients With Colorectal Cancer During the Initial Phase of the COVID-19 Pandemic

Vascular Endothelial Growth Factor Antagonists as Anticancer Agents